Home›Companies›Biotech & Pharma›VST BIO

VST Bio Corp.

Develops antibody treatments for people with stroke and other cardiovascular diseases.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Apr 24, 2026·Suggest an edit

About VST BIO

VST BIO is a private company based in San Diego, California. It has reported $31,888,146 raised in one offering on Form D since November 2025. Its chief executive is Krisztina Zsebo.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 5, 2025Nov 18, 2025amended Apr 24, 2026$31,888,146fully sold1$31.8MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on VST BIO's Form D filed Apr 24, 2026.

Rebecque Laba
Rebecque Laba
Chief Operating Officer
WS
William Sessa
Board of Directors
JW
J. Ware
Director
Chris Somerville
Chris Somerville
Board of Directors
Krisztina Zsebo
Krisztina Zsebo
Co-Founder, CEO, Chairman of the Board

Sources

  1. SECVST BIO Corp Form D, filed Nov 18, 2025
  2. SECVST BIO Corp filing history
  3. CompanyLeadership team
  4. CompanySeries A announcement